Research collaboration opportunity to develop mycoviruses SlaGemV-1 and SsHADV-1 as biorational biofertilizers, seed treatments, and biopesticides. These fungal viruses have demonstrated ability to promote plant growth and suppress fungal pathogens, with potential applications across multiple crops including tomato, dry bean, soybean, basil, and sunflower.
This research program focuses on developing mycoviruses—viruses that infect fungi—as innovative biorational products for agriculture. Two specific mycoviruses, SlaGemV-1 and SsHADV-1, are being evaluated as three distinct product types: soil inoculants (biofertilizers), seed treatments, and foliar spray biopesticides. Preliminary results show strong potential: a hypovirulent strain of Sclerotinia sclerotiorum infected with SlaGemV-1 has demonstrated the ability to promote dry bean growth when mixed into potting soil and to suppress fungal infection when applied as a foliar spray. Notably, SlaGemV-1 virion extracts have achieved up to 100% suppression of fungal infection in foliar applications, with a clear dose-response relationship.
The research aims to optimize delivery methods across multiple crop systems, offering a sustainable alternative to conventional chemical inputs. This approach aligns with growing market demand for environmentally responsible crop protection and plant health solutions.
Core technology:
Delivery methods under investigation:
Validation completed:
The technology is at an advanced validation stage with greenhouse and field trials completed across multiple crops (tomato, dry bean, soybean, basil, and oilseed sunflower). Key efficacy data has been established for foliar spray applications, including demonstrated dose-response relationships and up to 100% fungal suppression in certain conditions. Seed treatment applications have shown less promising results to date, requiring further optimization. Next steps involve optimizing application rates and conditions across two moderately susceptible crop varieties, refining tissue production methods for crude viral particle extracts, and benchmarking performance against existing biorational products in the market. The program is positioned for collaborative development with industry partners to accelerate commercialization.
USDA is a U.S. federal executive department with an applied R&D enterprise delivered through a nationwide network of laboratories, field stations, and specialized repositories. Facilities include pilot‑scale processing lines and testbeds at co‑located university sites and research farms, enabling real‑world evaluation and scale‑up with USDA scientists. USDA engages industry through CRADAs, material transfers, cooperative field trials, and works with the Cooperative Extension System to speed adoption. Research is primarily supported by federal appropriations, with additional interagency collaborations and competitively funded programs. A dedicated tech transfer office manages IP and licensing and streamlines public‑private agreements.